do glp 1 decrease inflammation Antiinflammatory actions of glucagon-like peptide-1–based therapies beyond metabolic benefits GLP-1 Therapies May Benefit MPN

People are searching for simpler, more affordable ways to take control of their hunger.

Oral semaglutide delivered meaningful reductions in HbA1c and body weight among GLP-1RA-nave adults with type 2 diabetes in a Dutch real-world cohort

A recent study, published in the Journal of Pharmacy and Pharmacology Research, sugges

Diabetic patients prescribed tirzepatide, semaglutide, dulaglutide, and exenatide are less likely to be diagnosed with depression after starting the medication compared to those not on a glucagon-like peptide-1 receptor agonist (GLP-1) medication.

Discover features, costs, and GLP-1 medication options.

A new Cleveland Clinic study found those taking GLP-1s were less likely to develop stage IV disease in several cancer types, when compared to patients taking another diabetes medication, DPP-4 inhibitors